Description
Numelvi® (atinvicitinib tablets) is an oral prescription medication used to control pruritus associated with allergic dermatitis in dogs 6 months of age and older. It targets the underlying itch and inflammation pathways to provide effective relief while supporting simple, consistent treatment routines. This therapy helps improve comfort and quality of life for dogs affected by allergic skin conditions.
- Second-generation JAK inhibitor designed for targeted itch control
- Highly selective for JAK1, the primary driver of itch and inflammation
- Onset of itch relief within 2 to 4 hours
- Demonstrated significant improvement in itch within one week in clinical studies
- Once-daily oral dosing suitable for dogs 6 months and older weighing at least 2 kg
